709c86da-bfee-4e13-a3b0-941ac3ae7ce4_788x922
What Will It Take for a New Standard of Care in Cognitive Decline?
This week I came across an article about Lequembi, a treatment for Alzheimer’s disease. It is a new formulation of Lecanemab and what stood out was how simple it has become to administer.
Patients can now inject it themselves at home. It represents the culmination of decades of pharmaceutical development: a drug that’s easier than ever to deliver, more accessible than ever, and yet still fundamentally limited in what it can achieve.
